Bradykinine-associated angioedema and quality of life

Bradykinine-associated angioedema and quality of life - QOLA - Quality of Life with angioedema

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017374

Enrollment

Registered

2019-05-28

Start date

2019-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D84.1

Interventions

Group 1: Paper based questionnaires - clinical questionnaire concerning private and professional life, therapy, leisure time - following validated questionnaires: Angioedema control score (ACS), The

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age >18 years, medically diagnosed hereditary or acquired angioedema, consent for data protection declaration

Exclusion criteria

Exclusion criteria: Age <18 years, no signed consent of data protection declaration

Design outcomes

Primary

Measure	Time frame
questionnaire-based study Primary Goal: Evaluation of completed questionnaires concerning disease activity, therapy, Quality of life and psychosocialcomorbidities in patients suffering from hereditary and acquired angioedema	—

Secondary

Measure	Time frame
see above, method: questionnaire-based study	—

Countries

Germany

Contacts

Public ContactJulia Zarnowski

Klinik für Dermatologie, Venerologie und Allergologie des Universitätsklinikums Leipzig

julia.zarnowski@medizin.uni-leipzig.de0341 97 20191

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026